Shenzhen New Industries Biomedical Engineering

Shenzhen New Industries Biomedical Engineering is a company listed under the stock ticker 300832 (CN).

View the org chart displaying its 1 main executives

Most searched biographies at Shenzhen New Industries Biomedical Engineering

• Wei Rao, Chairman and General Manager

Create your alert
to follow the executive moves at Shenzhen New Industries Biomedical Engineering.

Shenzhen New Industries Biomedical Engineering has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Shenzhen New Industries Biomedical Engineering

Social media about Shenzhen New Industries Biomedical Engineering

• Shenzhen New Industries Biomedical Engineering on Wikipedia, Google News & Yahoo Finance
• Shenzhen New Industries Biomedical Engineering on LinkedIn, Twitter & YouTube

Call Shenzhen New Industries Biomedical Engineering at +86 755 ...

View the org chart

Register to receive your alert

Report an error